Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
Diabetes, Obesity & Metabolism|September 13, 2023
Tirzepatide reduces the predicted risk of developing type 2 diabetes in people with obesity or overweight: Post hoc analysis of the SURMOUNT-1 trialEmily R Hankosky, Hui Wang, Lisa M Neff, et al.
The Annals of Thoracic Surgery|February 20, 2007
Complications of video-assisted thoracoscopic lung biopsy in patients with interstitial lung diseaseMary Elizabeth Kreider, John Hansen-Flaschen, Nadia N Ahmad, et al.
Cardiovascular Diabetology|March 10, 2023
General versus central adiposity as risk factors for cardiovascular-related outcomes in a high-risk population with type 2 diabetes: a post hoc analysis of the REWIND trialEdward Franek, Prem Pais, Jan Basile, et al.
Diabetes, Obesity & Metabolism|November 6, 2023
Tirzepatide reduces the predicted risk of atherosclerotic cardiovascular disease and improves cardiometabolic risk factors in adults with obesity or overweight: SURMOUNT-1 post hoc analysisEmily R Hankosky, Hui Wang, Lisa M Neff, et al.
Heart (British Cardiac Society)|July 31, 2024
Tirzepatide and blood pressure reduction: stratified analyses of the SURMOUNT-1 randomised controlled trialHarlan M Krumholz, James A de Lemos, Naveed Sattar, et al.
Obesity Science & Practice|July 2, 2025
Exploring the Role of Internalized Weight Bias as a Metric of Cumulative Social Disadvantage Among People With Obesity or Overweight: Insights From the OBSERVE StudyJamy Ard, Julia P Dunn, Hong Kan, et al.
The New England Journal of Medicine|June 3, 2022
Tirzepatide Once Weekly for the Treatment of ObesityAnia M Jastreboff, Louis J Aronne, Nadia N Ahmad, et al.
Nature Medicine|October 15, 2023
Tirzepatide after intensive lifestyle intervention in adults with overweight or obesity: the SURMOUNT-3 phase 3 trialThomas A Wadden, Ariana M Chao, Sriram Machineni, et al.
Obesity (Silver Spring, Md.)|December 8, 2022
Tirzepatide for the treatment of obesity: Rationale and design of the SURMOUNT clinical development programCarel W le Roux, Shuyu Zhang, Louis J Aronne, et al.
Population Health Management|April 2, 2025
Perspectives on Obesity Management and the Use of Anti-Obesity Medicine from US Employees and Employers: Results from the OBSERVE StudyJamy Ard, Lee M Kaplan, Scott Kahan, et al.
Pageof 3